163 related articles for article (PubMed ID: 28577928)
1. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin for High-grade Non-muscle-invasive Bladder Cancer.
Sihra N; Diasuke N; Thurairaja R; Khan MS; Malde S
Urology; 2017 Sep; 107():e3-e4. PubMed ID: 28577928
[TBL] [Abstract][Full Text] [Related]
2. Reiter's syndrome postintravesical Bacillus Calmette-Guérin instillations.
Ng KL; Chua CB
Asian J Surg; 2017 Apr; 40(2):163-165. PubMed ID: 25183290
[TBL] [Abstract][Full Text] [Related]
3. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
[TBL] [Abstract][Full Text] [Related]
4. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
Kaneko T; Fujita K; Homma Y
Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629
[TBL] [Abstract][Full Text] [Related]
5. Isolated renal tuberculosis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer.
Wada Y; Sugiyama Y; Kikukawa H; Kuwahara T; Takahashi W; Takamiya T; Ueda S
Urol Int; 2004; 72(3):257-60. PubMed ID: 15084773
[TBL] [Abstract][Full Text] [Related]
6. BCG pyelonephritis following intravesical therapy for transitional cell carcinoma.
Garcia JE; Thiel DD; Broderick GA
Can J Urol; 2007 Apr; 14(2):3523-5. PubMed ID: 17466161
[TBL] [Abstract][Full Text] [Related]
7. Granulomatous renal masses following intravesical bacillus Calmette Guérin therapy: the central unaffected calyx sign.
Senés AT; Badet L; Lyonnet D; Rouvière O
Br J Radiol; 2007 Oct; 80(958):e230-3. PubMed ID: 17959911
[TBL] [Abstract][Full Text] [Related]
8. Late-onset granulomatous prostatitis following intravesical bacille Calmette-Guerin therapy: case report.
Castillo Cádiz O; Villasenín Parrado L; Borgna Christie V; Gallegos Méndez I; Martínez Corta V
Medwave; 2016 Jun; 16(5):e6473. PubMed ID: 27391977
[TBL] [Abstract][Full Text] [Related]
9. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
10. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer.
Ersoy O; Aran R; Aydinli M; Yonem O; Harmanci O; Akdogan B; Pinar A; Sokmensuer C; Bayraktar Y
Indian J Gastroenterol; 2006; 25(5):258-9. PubMed ID: 17090848
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo--an autoimmune side-effect of intravesical bacillus Calmette-Guérin instillation?
Beisland C; Holsen DS
Scand J Urol Nephrol; 2004; 38(2):182-3. PubMed ID: 15204415
[TBL] [Abstract][Full Text] [Related]
12. Abdominal aortic aneurysmal and endovascular device infection with iliopsoas abscess caused by Mycobacterium bovis as a complication of intravesical bacillus Calmette-Guérin therapy.
Mizoguchi H; Iida O; Dohi T; Tomoda K; Kimura H; Inoue K; Iwata T; Tei K; Miura T
Ann Vasc Surg; 2013 Nov; 27(8):1186.e1-5. PubMed ID: 23972639
[TBL] [Abstract][Full Text] [Related]
13. [Imaging findings in BCGitis--Bacillus-Calmette-Guérin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
Kaufmann S; Amend B; Kruck S; Gakis G; Bedke J; Horger M
Rofo; 2015 Aug; 187(8):623-7. PubMed ID: 26218471
[No Abstract] [Full Text] [Related]
14. [Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report].
Muranaka T; Kunishima Y; Shigyo M; Kato R; Masumori N; Ito N; Tsukamoto T; Takagi Y; Seki M; Toida I
Hinyokika Kiyo; 2007 Aug; 53(8):581-4. PubMed ID: 17874552
[TBL] [Abstract][Full Text] [Related]
15. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
Pfister C; Kerkeni W; Rigaud J; Le Gal S; Saint F; Colombel M; Guy L; Wallerand H; Irani J; Soulie M;
Int J Urol; 2015 Jan; 22(1):53-60. PubMed ID: 25256813
[TBL] [Abstract][Full Text] [Related]
17. [A Case Report of Granulomatous Renal Masses Following Intravesical Instillation of Bacillus Calmette-Guérin Therapy].
Kuramoto T; Nishikawa T; Nanpou Y
Hinyokika Kiyo; 2018 May; 64(5):225-230. PubMed ID: 30064162
[TBL] [Abstract][Full Text] [Related]
18. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
19. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guérin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer.
Kocak SY; Kudu A; Apaydın S
J Cancer Res Ther; 2021; 17(2):609-612. PubMed ID: 34121722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
